Brief: Yichang Hec Changjiang Pharmaceutical Posts FY Revenue RMB913.79 Million, Down 61.08%
21/03/2022 15:01
March 21 (Reuters) - YiChang HEC ChangJiang Pharmaceutical:
* FY REVENUE WAS RMB913.79 MILLION, A DECREASE OF 61.08%
* FY LOSS AND TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE
RMB587.6 MLN
VS PROFIT OF RMB839.5 MLN
Further company coverage: 1558.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Yichang Hec Changjiang Pharmaceutical Co
See all newsBrief: Yichang Hec Changjiang Pharmaceutical Says Exchange Approved Withdrawal Of Listing Of H Shares
Brief: Yichang Hec Changjiang Pharmaceutical Says Encofosbuvir Tablets (0.3G) Approved For Launch By NMPA
Brief: Yichang HEC Changjiang Pharmaceutical Updates On Filing With Listing Committee
Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement
Brief: YiChang HEC Changjiang Pharmaceutical Posts HY Revenue RMB2,454.8 Million